Actively Recruiting
Scleroderma Registry & Repository at the Hospital for Special Surgery
Led by Hospital for Special Surgery, New York · Updated on 2025-11-26
300
Participants Needed
1
Research Sites
1222 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The overall objective of the Scleroderma Registry is to support and promote the basic science and clinical research of this complex rheumatic disease at the Hospital for Special Surgery (HSS). The registry facilitates our understanding of the clinical features, pathobiology, genetics of Scleroderma. This will ultimately lead to a potential treatment for this currently untreatable condition.
CONDITIONS
Official Title
Scleroderma Registry & Repository at the Hospital for Special Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Individuals older than 18 years of age with Scleroderma
You will not qualify if you...
- Individuals younger than 18 years of age
- Individuals older than 18 years of age without Scleroderma
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hospital for Special Surgery
New York, New York, United States, 10021
Actively Recruiting
Research Team
E
Eliza Pelrine, BA
CONTACT
E
Emily Bakaj, BA
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here